Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Department of Molecular and Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Methods Mol Biol. 2021;2291:317-332. doi: 10.1007/978-1-0716-1339-9_15.
Shiga toxin-producing Escherichia coli (STEC) and the related pathogen enteropathogenic Escherichia coli (EPEC) use a type III secretion system to translocate effector proteins into host cells to modulate inflammatory signaling pathways during infection. Here we describe the procedures to investigate effector-driven modulation of host inflammatory signaling pathways in mammalian cells where bacterial effectors are ectopically expressed or in cell lines infected with STEC or EPEC. We focus on the TNF-induced NF-κB response by examining IκBα degradation by immunoblot and p65 nuclear localization in addition to using an NF-κB-dependent luciferase reporter and cytokine secretion assays. These methods can be adapted for examining effector-mediated modulation of other inflammatory stimuli and host signaling pathways.
产志贺毒素大肠杆菌(STEC)和相关病原体肠致病性大肠杆菌(EPEC)使用 III 型分泌系统将效应蛋白转运到宿主细胞中,在感染过程中调节炎症信号通路。在这里,我们描述了研究在哺乳动物细胞中外源表达细菌效应蛋白或感染 STEC 或 EPEC 的细胞系中效应蛋白驱动的宿主炎症信号通路调节的程序。我们专注于 TNF 诱导的 NF-κB 反应,通过免疫印迹检查 IκBα 的降解和 p65 的核定位,以及使用 NF-κB 依赖性荧光素酶报告基因和细胞因子分泌测定法。这些方法可以适用于研究效应蛋白介导的其他炎症刺激物和宿主信号通路的调节。